Welcome to Sun-shine chemical
+86-17702719238 sales@sun-shinechem.com

Products

Catalog NoChemical NameCAS NumberPurityChemical Structure
6111413Roquinimex84088-42-698% 
Roquinimex (Linomide; PNU212616; ABR212616) is a quinoline derivative immunostimulant
6111024RHPS4390362-78-498% 
RHPS4 is a potent inhibitor of Telomerase at submicromolar.
611924RGB-286638784210-87-398% 
RGB-286638 is a novel CDK inhibitor with IC50s of 1 nM/2 nM/3 nM/4 nM/5 nM for cyclin
611909RK-331070773-09-998% 
RK-33 is an RNA helicase inhibitor against DDX3, and inhibit its helicase activity.RK
1673101RO89941309684-94-398% 
RO8994 is a potent and selective spiroindolinone MDM2 inhibitor for cancer therapy.
16071112RO5045337939981-39-298% by HPLC 
RO5045337, also known as R7112, RG7112, is a MDM2 antagonist with potential antineopl
16070103RSL 31219810-16-898% by HPLC 
RSL 3
16062107(R) QuinoxP(R)866081-62-197% by HPLC 
(R) QuinoxP(R)
166154Ro41-1049(HCl)127500-84-998% by HPLC 
Ro 41-1049 is an inhibitor of the enzyme monoamine oxidase type A(MAO-A).
16061501RS-1312756-74-498% by HPLC 
4-BroMo-N-(4-broMophenyl)-3-[[(phenylMethyl)aMino]sulfonyl]benzaMide;RAD51-stimulator
16060701Relugolix737789-87-698% by HPLC 
Relugolix, also known as TAK-385, is a luteinizing hormone-releasing hormone (LH-RH)
16060303RO31-8220 mesylate138489-18-698% by HPLC 
Ro 31-8220 is a PKC-inhibitor, which inhibits stimulated fluid pinocytosis of human P
031003R112575474-82-798% 
R112 is an ATP-competitive inhibitor of Syk kinase with a Ki of 96 nM. R112 inhibits
031001Ro 46-2005150725-87-498% 
Ro 46-2005 is a novel synthetic non-peptide endothelin receptor antagonist, inhibits
030909RAD1401182367-47-098% 
Coming soon!
011907Robalzotan tartrate hydrate169758-66-198% 
Coming soon!
011307Radotinib926037-48-198% 
Radotinib is an orally available, a second-generation tyrosine kinase inhibitor of Bc
01118Ruxolitinib941678-49-598% 
Ruxolitinib is the first potent, selective, JAK1/2 inhibitor to enter the clinic with
010812Ro 5126766946128-88-798% 
Ro 5126766 is a potent and selective dual RAF/MEK inhibitor. For SK-MEL-28, SK-MEL-2,
010810Refametinib923032-37-598% 
Refametinib is an orally bioavailable selective MEK inhibitor with potential antineop
010412Raltegravir518048-05-098% 
Raltegravir is a pyrrolidinone derivative and HIV INTEGRASE INHIBITOR that is used in
123018Ridaforolimus572924-54-098% 
Ridaforolimus is a selective mTOR inhibitor with IC50 of 0.2 nM; while not classified
123010R4281037624-75-198% 
R428 is a potent and selective small-molecule inhibitor(IC50=14 nM), blocks the activ
123005Rucaparib283173-50-298% 
Rucaparib is an inhibitor of PARP with Ki of 1.4 nM for PARP1, also showing binding a
123001RO4929097847925-91-198% 
RO4929097 is a secretase inhibitor with IC50 of 4 nM, inhibiting cellular processing
122928R788901119-35-598% 
Fostamatinib is a small molecule Syk kinase inhibitor with potential anti-inflammator
122927R406 free base841290-80-098% 
R406 is a potent inhibitor of immunoglobulin E (IgE)- and IgG-mediated activation of
122917RGB-286638 free base784210-88-498% 
RGB-286638 is a novel CDK inhibitor with IC50s of 1 nM/2 nM/3 nM/4 nM/5 nM for cyclin
122904Ravidasvir hydrochloride1303533-81-498% 
Ravidasvir is a second-generation, orally active, potent and selective HCV NS5A prote
122837Rofecoxib162011-90-798% 
Rofecoxib is a synthetic, nonsteroidal derivative of phenyl-furanone with antiinflamm